Health

HHS Peptide Plan and Pharma Stocks

Updated 2026-10-16 13:55 UTC 1 source Neutral

STAT News reported on the Trump administration's plan to allow compounding pharmacies to produce certain peptides. The article also touched on former President Trump’s stock holdings in pharmaceutical companies.

Coverage timeline — 2 articles

STAT News

STAT+: RevMed’s pancreatic cancer drug nears European approval

Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.

2026-10-16 13:38 UTC

STAT News

STAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more

The Trump administration is proceeding with a plan to allow compounding pharmacies to produce certain peptides

2026-10-16 13:49 UTC